Elevated 2-h plasma glucose concentration (2hPG) from an oral glucose tolerance (OGTT) test more strongly predicts risk of subsequent cardiovascular disease than fasting plasma glucose (FPG), but the association between these glucose measurements and hypertension risk is less clear. We examined the association between 2hPG, FPG and risk of hypertension. We conducted a prospective observational study (The Australian Diabetes, Obesity and Lifestyle Study-AusDiab) among 4413 Australian residents who attended a baseline (1999)(2000) and follow-up (2004-2005) examinations. Measurements included blood pressure (mean of two readings), 75 g OGTT, fasting insulin, anthropometrics, dietary and alcohol intake, medical history and physical activity. Hypertension was defined as a systolic blood pressure (SBP)X140 or a diastolic blood pressure (DBP)X90 mm Hg or treatment with medication for hypertension.
Introduction
Diabetes mellitus and impaired glucose tolerance (IGT) are strongly associated with the presence of hypertension and the development of cardiovascular disease (CVD). 1, 2 Both fasting (FPG) and 2-h (2hPG) plasma glucose concentrations obtained during the course of an oral glucose tolerance test (OGTT) are related to a higher future risk of CVD events, although a study of several ethnic groups from Pacific and Indian Ocean Islands and the DECODE study demonstrated that the 2hPG was more strongly related to this outcome than FPG. [3] [4] [5] Compelling evidence on the association between 2hPG and the risk of hypertension comes from the STOP-NIDDM randomized clinical trial. 6 This study demonstrated that treatment over an average time of 3.3 years with acarbose, a medication that reduces postprandial glucose level, resulted in a reduction in the occurrence of new-onset diabetes, CVD, and hypertension in overweight or obese persons with IGT. A 25% reduction in the risk of developing diabetes based on elevated 2hPG was observed, and even larger proportional reductions in the risk of new onset CVD and hypertension. These findings implicate a potential role for 2hPG in the causation of hypertension, and raise the possibility that the adverse effects of 2hPG on CVD outcomes may be mediated at least partially through an elevation in blood pressure.
Few prospective studies have examined the association between glycaemia and subsequent risk of hypertension. [7] [8] [9] [10] [11] [12] Those that have specifically examined 2hPG have not optimally assessed this association for various reasons, including probable low power due to small sample size, non-standard measurement of blood pressure, obsolete definition of hypertension or lack of adjustment for insulin resistance. 7, 8, 10, 12 Most other research on this question is cross-sectional and hence cannot provide information on temporal sequence as is needed to properly assess presence of a potential causal association. 9, 13 We examined whether higher 2hPG level following a 75 g oral glucose load was related to the development of hypertension over a 5-year follow-up in a national Australian cohort study.
Methods
Design and study population The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) began as a cross-sectional national prevalence survey that included 11 247 adults age 25 years and older from 42 clusters in six states and the Northern Territory of Australia. Detailed methods have been previously reported.
14-16 A 5-year followup survey was subsequently conducted, in which 6400 adults participated in the on-site testing. Persons who completed the baseline and follow-up on-site examinations comprise the population included in this analysis. The baseline and follow-up examination protocols were reviewed and approved by the International Diabetes Association Ethics Committee and all subjects gave informed consent.
Data collection
Participants presented to the local survey centre in the morning following an overnight fast. Measurement methods included an interview that assessed general health and demographic characteristics, level of exercise using the Active Australia Survey questionnaire and a self-administered validated food frequency questionnaire. [17] [18] [19] Physical activity included walking for recreation or transport and other moderate or vigorous activities. The questions used in this assessment have been found to provide reliable and valid estimates of adult physical activity. 17, 20 Total physical activity time for the previous week equalled the sum of the time spent walking (if continuous and X10 min) or performing moderate physical activity plus double the time spent in vigorous physical activity, and was categorized as follows as per Australian national health recommendations: none, 1-149 and X150 min. 17 Calculation of nutrient intake (including alcohol) was achieved by multiplying the frequency of consumption by standard portion weights, which were then converted into nutrient intakes based on the NUTTAB95 nutrient composition database. 19 Blood pressure was measured in the arm not used for blood drawing with the participant in a seated position after at least a 5-min rest. The participant's mid-upper arm circumference was measured to select the appropriate cuff size. At the baseline exam, a standard mercury sphygmomanometer was used in one state (Victoria) with blood pressure recorded within 2 mm Hg of the first and fifth Korotkoff sounds. For all other baseline and followup exams, a Dinamap semi-automatic oscillometric recorder was used (Critikon, Tampa, FL, USA). Based on a comparison study (conducted on every 20th person in the last six states surveyed (n ¼ 469)) of readings using the sphygmomanometer and the Dinamap, an adjustment was made to all diastolic blood pressure (DBP) readings recorded in the state using the sphygmomanometer as previously described. 21 Three measurements were taken at 1-min intervals. The final measure of blood pressure was defined as the mean of the first two readings, unless the difference between these readings was greater than 10 mm Hg, in which case the mean of the two closest of three measurements was used. Hypertension was defined as systolic blood pressure (SBP)X140 or DBPX90 mm Hg or self-reported use of anti-hypertensive medication.
Participants were instructed to fast for at least 10 h prior to presenting for an OGTT. A fasting blood sample was drawn followed by the participant drinking a 75 g glucose solution in 300 ml of fluid over o5 min, with subsequent blood drawn for the 2hPG determination. The specimens were centrifuged, plasma was separated immediately and plasma glucose levels were determined using an Olympus AU600 automated analyzer, which uses a glucose oxidase method (Olympus Optical Co. Ltd., Tokyo, Japan). Participants who reported a history of physician-diagnosed diabetes were classified as having known diabetes if they were also taking hypoglycaemic medication or had an FPG level X7.0 mmol l À1 or a 2hPG level X11.1 mmol l À1 .
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Newly diagnosed diabetes was present when either glucose criterion was met in the absence of a prior diabetes diagnosis. IGT was defined as FPG o7.0 mmol l À1 and 2hPG X7.8 mmol l À1 but o11.1 mmol l À1 ; impaired fasting glucose (IFG) as FPG X6.1 mmol l À1 and o7.0 mmol l À1 with 2hPG o7.8 mmol l À1 , and normal glucose tolerance as FPG o6.1 mmol l À1 and 2hPG o7.8 mmol l À1 . Serum samples for insulin were stored at À80 1C until assayed. Serum insulin was measured using a human insulin-specific radioimmunoassay kit (Linco Research Inc., St Charles, MO, USA). Insulin assays were conducted only for the population aged 435 years. The fasting insulin and glucose concentrations were used to calculate HOMA-S as a measure of insulin sensitivity using the HOMA2 Calculator. 23 Participants underwent a clinical evaluation that included measurements of height, weight and waist circumference as previously described. 24 Body fat mass and percent was estimated using a commercially available bioimpedance device (Tanita TBF 105 Body Fat Analyser, Tanita UK Ltd., Middlesex, UK).
Statistical analysis
The t-test was used to compare mean values and the w 2 -test for categorical comparisons. Logistic regression Two-hour glucose and risk of hypertension EJ Boyko et al analysis was used to estimate odds ratios (ORs) for exposures of interest while adjusting for covariates. 25 Adjustment for the clustered sampling was included in all logistic regression models using the cluster option in STATA (version 9.2, College Station, Texas) and the robust variance estimator. Multiple linear regression analysis was used to assess change in blood pressure in relation to FPG and 2hPG by modelling the 5-year measure (SBP or DBP) while adjusting for the baseline value of the same variable. 26 Locally weighted regression (lowess) was used to plot the association between hypertension risk transformed as the log odds in relation to 2hPG level. 27 The advantage of this method is that it does not require a global assumption about relationships between variables (for example, linear, hyperbolic) in the entire dataset.
Results
Of the 6400 participants who presented for both the baseline and follow-up examinations, the following numbers of participants were excluded from the analysis: hypertension at baseline (n ¼ 1987), missing blood pressure at baseline (n ¼ 29) or 5-year follow-up (n ¼ 31), inadequate fasting (o9 h) prior to the OGTT (n ¼ 6) and pregnancy at baseline (n ¼ 23) or follow-up (n ¼ 18).
Participants who developed hypertension had at baseline on average greater age, body mass index (BMI), waist circumference, percent body fat, FPG, 2hPG, SBP, DBP, daily alcohol intake and lower HOMA-S (Table 1) . They were also more likely to be former smokers, male, less educated and have any type of glucose abnormality (Table 1) . Total dietary energy intake and level of exercise did not differ between groups.
Multivariable analyses demonstrated that 2hPG significantly predicted hypertension occurrence independently of other potential confounding variables in all 10 models shown in Table 2 , including age and gender (Model 1), FPG (Model 2), HOMA-S (Models 3 and 5), BMI and waist circumference (Model 4) and smoking, education, exercise, alcohol intake and change in BMI and waist circumference (Models 5-10). The significant association between FPG and hypertension risk became smaller and nonsignificant after adjustment for HOMA-S (Model 3) or BMI and waist circumference (Model 4). HOMA-S was significantly related to risk of hypertension independent of age, gender, FPG and 2hPG (Model 3, Table 2 ), but this association diminished after additional adjustment for baseline BMI and waist circumference (Model 5). Further adjustment of Model 9 for HOMA-S (Model 10) or total daily energy intake similarly had little effect on the significant association between 2hPG and hypertension risk (data not shown). Baseline SBP adjustment in Models 8-10 or DBP (data not shown) similarly had little effect on the magnitude of hypertension risk associated with 2hPG. Use of percent body fat in place of BMI led to similar results in Models 4-10. To consider whether 2hPG was associated with a higher risk of hypertension independent of incident diabetes occurring during follow-up, we adjusted Model 1 for incident diabetes but found no effect on the strength of association between 2hPG and hypertension risk (OR 1.26, 95% CI 1.13-1.41).
Additional analyses were performed with different outcome definitions and exclusion criteria. Models 1-10 were repeated after exclusion of participants with known diabetes at baseline. The outcome was also redefined in two different ways as anti-hypertensive medication treatment only or meeting blood pressure criteria without current anti-hypertensive medication treatment. The association between the risk of the outcome and 2hPG remained statistically significant despite these alternative outcome definitions and exclusion criteria (data not shown).
Further analyses included testing the assumption of linearity in Model 1 with a quadratic transformation of 2hPG (2hPG 2 ), but this term was nonsignificant. A smoothed plot of the log odds of incident hypertension by 2hPG as a continuous measure (Figure 1 ) also demonstrated a linear relationship. A first-order gender Â 2hPG interaction term was added to Model 9, Table 2 , but was not found to be significant (coefficient 0.080, 95% CI À0.004 to 0.164, P ¼ 0.063). No significant interaction was seen between 2hPG and age, baseline BMI or change in BMI, as previously observed. 7 Additional analyses assessed whether baseline 2hPG and FPG predicted changes in SBP or DBP as continuous variables over 5 years (Table 2 ). These models used the same inclusion/exclusion criteria as for analysis of hypertension as a dichotomous outcome. Similar results was seen with 2hPG significantly and positively related to the change in SBP in 9 of 10 models. FPG became nonsignificantly related to SBP change after adjustment for either HOMA-S or BMI and waist circumference (Models 3-4). The significant association between DBP change and 2hPG (Models 1-3) diminished when measures of adiposity were included (Models 4-10). Similar results were seen in Models 1-10 after excluding persons on anti-hypertensive medication at the 5-year visit, and in Models 9-10 after adjustment for total daily energy intake. FPG level was not significantly related to DBP change (Models 2-10).
Discussion
We found that higher 2hPG concentration, obtained during a standard OGTT, was significantly related to the development of hypertension over 5 years in a national sample of Australian adults. This relationship could not be explained by other measured variables that were associated with 2hPG, including HOMA-S, FPG, BMI, waist circumference and incident diabetes occurrence. In addition, other factors potentially related to hypertension did not explain the association with 2hPG, including change in weight, BMI or waist circumference; education; level of exercise; gender; baseline blood pressure or smoking status. The association between 2hPG and hypertension risk appeared to be linear, and the effect was present in the non-diabetic range, as shown by the persistence of the association even after exclusion of persons at baseline with known diabetes. The magnitude of the association between 2hPG and hypertension risk was modest, with a 12-24% increase depending on adjustments in the odds of hypertension with a one s.d. increase (approximately 2 mmol l À1 ) in the 2hPG (Table 2) . Given this finding, other risk factors must also play important roles in determining future risk of hypertension. The association between baseline 2hPG and continuous blood pressure change was stronger for SBP than DBP.
Other prospective investigations of the association between postprandial glycaemia and risk of hypertension have yielded inconsistent findings. In the Paris Prospective Study that included men only, 2hPG was related to a higher risk of incident hypertension after adjustment for age, excessive alcohol consumption, BMI, iliac circumference and baseline SBP over an average follow-up of 3.16 years. 7 This effect was most pronounced among persons with a positive family history of hypertension. Non-standard methods were used to measure blood pressure (readings were rounded to the nearest 10 mm Hg) and hypertension was defined using an obsolete definition (X160/95 mm Hg). In the San Antonio Heart Study, 2hPG was significantly related to a higher risk of hypertension among women only over an 8-year follow-up in a model adjusted for age, ethnicity, subscapular skinfold Includes as a covariate baseline systolic or diastolic blood pressure, depending on the model. d Systolic blood pressure adjustment does not apply to models of the change in diastolic blood pressure.
Two-hour glucose and risk of hypertension thickness and BMI. 8 No adjustment was performed for insulin resistance, and the results presented utilized a non-standard definition of hypertension based on diastolic pressure only (X95 mm Hg). A small prospective comparison of 32 subjects with IGT and 92 with normal glucose tolerance produced the surprising result that IGT was significantly associated with a reduced risk of hypertension. 10 These findings must be viewed with scepticism due to the small number of outcome events overall (n ¼ 30), and in particular, the low ratio of these events to the number of independent variables in the final multivariable model (n ¼ 7, ratio 4.3:1). 28 The Strong Heart Study observed a higher risk of hypertension in relation to diabetes in 4549 American Indian subjects followed for 4 years, but did not consider 2hPG as a continuous independent variable in this analysis. 11 A prospective study of two large Japanese cohorts followed for 4 years observed a higher risk of hypertension among persons with IFG after adjustment for age, BMI, alcohol consumption, smoking, exercise and weight variation, but unfortunately lacked information on 2hPG. 9 A prospective study in Japanese Americans that included adjustment for visceral fat area measured by computed tomography reported an elevated risk of hypertension in association with 2hPG of similar magnitude to that observed in this study, but the result did not achieve statistical significance, possibly because of a much smaller sample size (n ¼ 300) and insufficient power. 12 The STOP-NIDDM trial offers support for a potential causal role of 2hPG in the development of hypertension by demonstrating that a reduction in 2hPG was accompanied by a lower incidence of incident hypertension. 6 Although body weight decreased by a statistically significant degree in the acarbose (À1.15 kg, À1.3%) compared to the placebo group ( þ 0.26 kg), the small magnitude of change on an absolute or proportional scale argues against the possibility that weight change explained the reduction in blood pressure. Few other trials of glucose lowering in persons without diabetes using a pharmaceutical intervention have been conducted. The Diabetes Prevention Program randomized subjects with IGT to lifestyle, metformin or to placebo to assess change in diabetes risk. 29 The metformintreated participants showed little change in 2hPG or risk of subsequent hypertension. 29, 30 Metformin mainly reduces fasting glycaemia by suppressing hepatic gluconeogenesis (a major determinant of FPG level), and it has a comparatively smaller effect on a change in peripheral insulin sensitivity (a major determinant of postprandial glycaemia). 31, 32 Potential causal mechanisms linking postprandial hyperglycaemia to the development of hypertension are speculative. One possible link is the creation of oxidative stress by hyperglycaemia through the production of free radicals. 33, 34 Hyperglycaemia induced by clamping and oral glucose loading has been shown to impair endothelium-dependent vasodilation, raising the possibility that resulting higher peripheral resistance may eventually lead to hypertension. 35, 36 Persons with essential hypertension exhibit greater peripheral than hepatic insulin resistance compared to controls. 37 As elevated 2hPG results mainly from peripheral resistance to the action of insulin on muscle glucose uptake as measured by clamp studies, while elevated FPG mainly results from hepatic insulin resistance as measured by HOMA, it is possible that higher 2hPG serves as a marker for lower peripheral insulin sensitivity. 32 Further research will be required to demonstrate whether 2hPG effects blood pressure independent of peripheral insulin sensitivity.
The adverse cardiovascular health effects of postprandial glucose are becoming increasingly recognized, and a recent expert committee emphasized the need for more attention to this clinical condition. 38 An increase in hypertension prevalence from a higher 2hPG may partially explain the higher risk of CVD in association with postprandial hyperglycaemia. A positive association between higher CVD death rate and both IGT and diabetes diagnosed by the 2hPG in the DECODE study persisted even after adjustment for SBP, suggesting an effect of glycaemia on CVD through a pathway other than blood pressure increase. 3 Alternatively, the persisting higher risk of CVD after blood pressure adjustment may represent residual confounding.
Limitations of this analysis include the possibility of unmeasured confounding factors that might account for the association between 2hPG level and risk of hypertension. This limitation is not unique to this investigation and would apply to any observational study. One such factor may be the size of the visceral adipose depot, which was not directly measured in this study, and which is associated with a higher risk of hypertension, although use of the waist circumference as a surrogate measure did not substantially alter the findings of this analysis. In one prospective study that did adjust for a direct measurement of visceral fat area, a nonsignificant Figure 1 Smoothed curve of the relationship between log odds of incident hypertension over the 5-year follow-up (y axis) in relation to 2-h plasma glucose as a continuous variable (x axis).
Two-hour glucose and risk of hypertension EJ Boyko et al increase in the risk associated with 2hPG was observed of similar magnitude as the present investigation. 12 Another potential confounding factor that was not measured is obstructive sleep apnoea, which has been associated with both diabetes and hypertension. 39 The loss to follow-up rate in this study exceeded 20%, a conventional standard beyond which the potential for bias increases if the pattern of missing subjects was not at random. 40 For example, if persons with higher 2hPG and subsequent lower blood pressure were more likely to be lost to follow-up, then this might create an apparent association between 2hPG and subsequent hypertension. However, this scenario is unlikely in our judgement. Furthermore only minor differences were noted at baseline between persons who did and did not attend the follow-up exam, with a 1% or smaller difference for the following measures: BMI, systolic and DBP, 2hPG and FPG (data not shown). The largest difference was seen for mean age of non-attendees (48.0 years) versus attendees (51.5 years). Measurement error due to less than perfect reproducibility of the OGTT may have occurred. 41 Such error, which would likely be random, would diminish observed associations, and, if present, would imply that a stronger association exists between 2hPG and risk of hypertension than reported in this paper. 42 One State used a different method to measure blood pressure, but the potential for this to cause bias in these findings is low since all analyses were adjusted for site.
In summary, 2hPG predicted subsequent hypertension, even at non-diabetic levels of glycaemia. The strength of association between 2hPG and risk of hypertension was modest but statistically significant. When change in blood pressure over 5 years as a continuous measure was examined as the outcome, 2hPG was more strongly and consistently related to change in SBP than DBP. These findings require confirmation from additional prospective observational research. If confirmed, and given that many treatments are available to reduce the level of postprandial glycaemia, new potential avenues for preventing some cases of hypertension and subsequently reduce CVD risk could become available. The positive public health impact of such interventions would be substantial given that the residual lifetime risk of hypertension in 55-65-year-old persons without hypertension based on Framingham data is estimated at 90%. 43 
